ProfileGDS4177 / 222287_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 17% 27% 4% 16% 66% 36% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated10.1117
GSM603099KU-812 non-treated13.1727
GSM603098KCL-22 Imatinib-treated6.744
GSM603097KCL-22 non-treated9.4216
GSM603102JURL-MK1 Imatinib-treated77.5366
GSM603101JURL-MK1 non-treated18.8336